Page last updated: 2024-08-24

aristeromycin and Prostatic Neoplasms

aristeromycin has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawamoto, T; Tanaka, Y; Uchiyama, N1

Other Studies

1 other study(ies) available for aristeromycin and Prostatic Neoplasms

ArticleYear
Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
    European journal of pharmacology, 2017, Oct-05, Volume: 812

    Topics: Adenosine; Adenosylhomocysteinase; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; MicroRNAs; Prostatic Neoplasms; RNA, Small Interfering; Transcriptional Activation

2017